Similar articles for PMID: 26960480

Year	Number of Results
2003	2
2006	3
2007	4
2008	3
2009	5
2010	2
2011	3
2012	10
2013	6
2014	8
2015	8
2016	6
2017	8
2018	7
2019	6
2020	4
2021	7
2022	4
2023	2
2024	0

1

Therapy and progression--induced O6-methylguanine-DNA methyltransferase and mismatch repair alterations in recurrent glioblastoma multiforme.

Agarwal S, Suri V, Sharma MC, Sarkar C. Agarwal S, et al. Indian J Cancer. 2015 Oct-Dec;52(4):568-73. doi: 10.4103/0019-509X.178403. Indian J Cancer. 2015. PMID: 26960480 Free article. Review.

2

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.

Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Kreth FW, Pietsch T, Löffler M, Weller M, Reifenberger G, Tonn JC; German Glioma Network. Felsberg J, et al. Int J Cancer. 2011 Aug 1;129(3):659-70. doi: 10.1002/ijc.26083. Int J Cancer. 2011. PMID: 21425258 Free article.

3

Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.

Metellus P, Coulibaly B, Nanni I, Fina F, Eudes N, Giorgi R, Barrie M, Chinot O, Fuentes S, Dufour H, Ouafik L, Figarella-Branger D. Metellus P, et al. Cancer. 2009 Oct 15;115(20):4783-94. doi: 10.1002/cncr.24546. Cancer. 2009. PMID: 19637364 Free article.

4

Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?

Tanaka S, Akimoto J, Narita Y, Oka H, Tashiro T. Tanaka S, et al. J Neurosurg. 2014 Oct;121(4):818-26. doi: 10.3171/2014.6.JNS132535. Epub 2014 Aug 8. J Neurosurg. 2014. PMID: 25105699

5

Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation status.

Matos B, Bostjancic E, Matjasic A, Popovic M, Glavac D. Matos B, et al. Radiol Oncol. 2018 Nov 26;52(4):422-432. doi: 10.2478/raon-2018-0043. Radiol Oncol. 2018. PMID: 30511935 Free PMC article.

6

Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.

Barbagallo GM, Paratore S, Caltabiano R, Palmucci S, Parra HS, Privitera G, Motta F, Lanzafame S, Scaglione G, Longo A, Albanese V, Certo F. Barbagallo GM, et al. Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502. Neurosurg Focus. 2014. PMID: 25434389

7

Effect of O6-Substituted Guanine Analogs on O6-methylguanine DNA-methyltransferase Expression and Glioblastoma Cells Viability.

St-Coeur PD, Cormier M, LeBlanc VC, Morin PJ, Touaibia M. St-Coeur PD, et al. Med Chem. 2016;13(1):28-39. doi: 10.2174/1573406412666160710210907. Med Chem. 2016. PMID: 27396904

8

O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.

Lechapt-Zalcman E, Levallet G, Dugué AE, Vital A, Diebold MD, Menei P, Colin P, Peruzzy P, Emery E, Bernaudin M, Chapon F, Guillamo JS. Lechapt-Zalcman E, et al. Cancer. 2012 Sep 15;118(18):4545-54. doi: 10.1002/cncr.27441. Epub 2012 Feb 22. Cancer. 2012. PMID: 22359215 Free article.

9

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Balaña C, Ramirez JL, Taron M, Roussos Y, Ariza A, Ballester R, Sarries C, Mendez P, Sanchez JJ, Rosell R. Balaña C, et al. Clin Cancer Res. 2003 Apr;9(4):1461-8. Clin Cancer Res. 2003. PMID: 12684420

10

Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity.

Hirose Y, Kreklau EL, Erickson LC, Berger MS, Pieper RO. Hirose Y, et al. J Neurosurg. 2003 Mar;98(3):591-8. doi: 10.3171/jns.2003.98.3.0591. J Neurosurg. 2003. PMID: 12650433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year